Cipla Ltd.
BSE: 500087 | NSE: CIPLA
Mid Cap | Pharmaceuticals & Drugs
1461.00
-0.55
(-0.04%)
< Home
< Back
Cipla Ltd. News
>>
Cipla moves up on the BSE
>>
Cipla moves up on the BSE
>>
Cipla gains on granting global commercialization rights for nasal spray ‘Dymista’ to Meda
>>
Cipla grants global commercialization rights for nasal spray ‘Dymista’ to Meda
>>
Cipla submits disclosure
>>
Cipla reports 8% fall in Q4 net profit
>>
Cipla fixes Book Closure for Dividend & AGM
>>
CIpla finally gets Medpro’s shareholders approval for acquisition
>>
Cipla moves up on receiving A1+ rating for short-term debt programme from India Ratings
>>
India Ratings assigns A1+ rating to Cipla’s short-term debt programme
<<
<
94
95
96
...104
>
>>
-0.55 (-0.04%) -0.55 (-0.04%)